Stereotactic Surgery Devices Market Size

Stereotactic Surgery Devices Market size is poised to reach USD 44 Billion by the end of 2036, growing at a CAGR of 5.7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of stereotactic surgery devices was USD 26 Billion. The reason behind the growth is due to the rising cases of cancer across the globe. Stereotactic radiosurgery, such as Gamma Knife, is a three-dimensional surgical technique and a very precise form of therapeutic radiation that is often used to treat noncancerous (benign), cancerous (malignant) brain tumors, and also to treat small, early-stage lung cancer and pancreatic cancer, or cancers that have spread to the lung, liver, or adrenal gland.

For instance, Cancer is one of the world's top causes of death, accounting for more than 9 million deaths in 2020, and it is anticipated that by 2040, there will be more than 27 million new cancer cases worldwide.

The growing technological advancements are believed to fuel the market growth. Stereotactic radiation is constantly being improved, owing to technological advances that aid in boosting treatment precision.

Frequently Asked Questions (FAQ)

Rising cases of cancer across the globe and growing technological advancements are the major factors driving the growth of the market.

The market size of Stereotactic Surgery Devices is anticipated to attain a CAGR of 5.7% over the forecast period, i.e., 2024-2036.

The major players in the market are Hitachi Medical Systems, Huiheng Group, Siemens AG, Elekta AB, Varian Medical Systems, IBA, Accuray Incorporated, GE Healthcare, and others.

The breast segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Stereotactic Surgery Devices Market Size